US Patent Issued to Ambros Therapeutics on June 16 for "Methods of selectively treating complex regional pain syndrome type I (CRPS-I) using bisphosphonate derivatives" (California Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,834, issued on June 16, was assigned to Ambros Therapeutics Inc. (Irvine, Calif.).

"Methods of selectively treating complex regional pain syndrome type I (CRPS-I) using bisphosphonate derivatives" was invented by Gregory J. Flesher (Irvine, Calif.) and Gail Cawkwell (Irvine, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of selectively treating Complex Regional Pain Syndrome ("CRPS") Type 1 using aminobisphosphonates."

The patent was filed on July 17, 2025, under Application No. 19/272,505.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p...